Monopar Therapeutics (MNPR) stock
MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$71.06−0.91 (-1.26%)
Close on Nov 17, 2026Market cap $476.97MP/E –Yield –
Monopar Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Monopar Therapeutics's market cap was $481.46M on Nov 11, 2026, against $574.21M a year earlier. Over the last 5 years it ranged from $4.12M to $751.29M, with a median of $38.93M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $481.46M | +10.7% |
| 2025 | Dec 31, 2025 | $435.09M | +461.0% |
| 2024 | Dec 31, 2024 | $77.55M | +1505.5% |
| 2023 | Dec 29, 2023 | $4.83M | -84.1% |
| 2022 | Dec 30, 2022 | $30.47M | -24.6% |
| 2021 | Dec 31, 2021 | $40.42M | -42.3% |
| 2020 | Dec 31, 2020 | $70.09M | -54.6% |
| 2019 | Dec 31, 2019 | $154.24M | – |
See a number that looks wrong?